Clinical Trials Browser

OTHER × Renal Insufficiency × daratumumab × Clear all

NCT04352205 2024-07-01

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Phase 2 Terminated

Multiple Myeloma, Renal Insufficiency